processesCarbonyl reduction is a significant step in the biotransformation leading to the elimination, of endogenous and exogenous aldehydes, ketones and quinones. This reaction is mediated by members of the aldoketo reductase and short-chain dehydrogenaseheductase (SDR) superfamilies. The essential role of these enzymes in protecting organisms from damage by the accumulation of toxic carbonyl compounds is generally accepted, although their physiological roles are not always clear. Recently, the SDR enzyme 1 1P-hydroxysteroid dehydrogenase-I has been identified to perform an important role in the detoxification of non-steroidal carbonyl compounds, in addition to metabolising its physiological glucocorticoid substrates. This review summarises the current knowledge of type-1 1 1P-hydroxysteroid dehydrogenase and discusses possible substratehnhibitor interactions. They might impair either the physiological function of glucocorticoids or the detoxification of non-steroid carbonyl compounds.Keywords: aldehyde ; ketone and quinone detoxification ; nicotine-derived nitrosamine ketone, carbonyl reduction; reductive metabolism; 1 I@-hydroxysteroid dehydrogenase ; short-chain dehydrogenasekeductase ; steroid metabolism ; microsomal reductase ; xenobiotic metabolism.Over the last decade 1 lp-hydroxysteroid dehydrogenases (1 1P-HSD) have received increasing attention from the scientific community. These enzymes have a multitude of (patho)physiological functions and a wide tissue distribution of isoforms. The key role of their enzymatic activity is the metabolism of physiologically occurring glucocorticoids, i.e. the 1 1P-oxidoreduction of cortisol (corticosterone) and cortisone (dehydrocorticosterone).However, in 1993 it was discovered that hepatic 11P-HSD-1, in addition to its role in the metabolism of physiological steroid substrates, is also capable of catalysing the carbonyl reduction of non-steroid xenobiotic aldehydes, ketones and quinones [ 1,